OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

Rhea-AI Summary

OraSure Technologies (NASDAQ: OSUR) has scheduled its Q4 2024 earnings conference call for February 25, 2025, at 5 p.m. ET. The company will discuss fourth quarter financial results and business developments during the call.

A webcast will be available on OraSure's investor relations website, with registration required at least 10 minutes before the call. The webcast recording will be accessible for approximately 90 days after the event. Participants who wish to ask questions during the call must pre-register through a provided link to receive access details.

BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET on February 25, 2025.

A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.

For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.

https://register.vevent.com/register/BI400ff7eb0f2149dfa53af33625f6bdfb

About OraSure Technologies, Inc. 
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com

Investor Contact: Jason Plagman VP, Investor Relations investorinfo@orasure.com

Media Contact: Amy Koch Director, Corporate Communications media@orasure.com

FAQ

When is OraSure Technologies (OSUR) reporting Q4 2024 earnings?

OraSure Technologies (OSUR) will report its Q4 2024 earnings on February 25, 2025, at 5 p.m. ET.

How can investors access OraSure's Q4 2024 earnings call?

Investors can access the earnings call through a webcast on OraSure's investor relations website. Pre-registration is required for those wanting to ask questions during the call.

How long will OraSure's Q4 2024 earnings webcast be available?

The webcast will be archived on OraSure's website for approximately 90 days after the call.

Do investors need to register in advance for OraSure's Q4 2024 earnings call?

Yes, investors need to register at least 10 minutes prior to the call, and those wanting to ask questions must pre-register through a specific link to receive access details.